Postmenopausal hormone therapy and quality of life

[1]  F. Naftolin,et al.  Guidelines for the hormone treatment of women in the menopausal transition and beyond. , 2005, Climacteric : the journal of the International Menopause Society.

[2]  K. Maki,et al.  A Multicenter, Open-Label Study to Evaluate Satisfaction and Menopausal Quality of Life in Women Using Transdermal Estradiol/Norethindrone Acetate Therapy for the Management of Menopausal Signs and Symptoms , 2005, Gynecologic and Obstetric Investigation.

[3]  C. Acquadro,et al.  Literature review of instruments to assess health-related quality of life during and after menopause , 2005, Quality of Life Research.

[4]  D. Grové,et al.  Current patient perceptions on the menopause: a South African perspective , 2005, Climacteric : the journal of the International Menopause Society.

[5]  H. Burger,et al.  Guidelines for hormone treatment of women in the menopausal transition and beyondPosition Statement by the Executive Committee of the International Menopause Society (Revised October 15, 2004) , 2004, Climacteric : the journal of the International Menopause Society.

[6]  M. Hammar,et al.  Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy. , 2004, Maturitas.

[7]  W. Utian,et al.  Effect of raloxifene on quality of life: a prospective study using the Utian Quality of Life (UQOL) Scale , 2004, Menopause.

[8]  T. B. Üstün,et al.  Global burden of depressive disorders in the year 2000 , 2004, British Journal of Psychiatry.

[9]  Nicola J Cooper,et al.  Benefits and harms associated with hormone replacement therapy: clinical decision analysis , 2004, BMJ : British Medical Journal.

[10]  J. Blümel,et al.  Patients' and clinicians' attitudes after the Women's Health Initiative study , 2004, Menopause.

[11]  Jan Scott,et al.  Global burden of depression: The intersection of culture and medicine , 2003, British Journal of Psychiatry.

[12]  J. Manson,et al.  Effects of estrogen plus progestin on health-related quality of life. , 2003, The New England journal of medicine.

[13]  A. Strothmann,et al.  Hormone therapy: the European women's perspective , 2003, Climacteric : the journal of the International Menopause Society.

[14]  M. Schluchter,et al.  The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause , 2002, Menopause.

[15]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[16]  E. Vittinghoff,et al.  Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. , 2002, JAMA.

[17]  E. Alder.  The Blatt-Kupperman menopausal index: a critique. , 1998, Maturitas.

[18]  J. Greene.  Constructing a standard climacteric scale. , 1998, Maturitas.

[19]  Earl R. Babbie,et al.  The practice of social research , 1969 .

[20]  P. Kenemans,et al.  Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life. , 2004, Drugs.